Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

A systematic review of existing medicines has found that antibiotics and vaccinations are associated with a reduced risk of ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Researchers from the universities of Cambridge and Exeter identified several medications - already licensed and in use - with ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

“Most of my new patients come through word of mouth,” says Dr. Boling. Her advice: Look at neighborhood chat groups. Ask friends who their doctors are and why they like them. Have a friend who’s a ...

Police have charged a man with murder after the body of Maroumbin father, Anmoral Bajwa, was discovered under a picnic table ...